LU87268A1 - Composition pharmaceutique a base d'analogues de la somatostatine - Google Patents

Composition pharmaceutique a base d'analogues de la somatostatine Download PDF

Info

Publication number
LU87268A1
LU87268A1 LU87268A LU87268A LU87268A1 LU 87268 A1 LU87268 A1 LU 87268A1 LU 87268 A LU87268 A LU 87268A LU 87268 A LU87268 A LU 87268A LU 87268 A1 LU87268 A1 LU 87268A1
Authority
LU
Luxembourg
Prior art keywords
signifies
alkyl
phe
group
hydrogen
Prior art date
Application number
LU87268A
Other languages
English (en)
French (fr)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878716326A external-priority patent/GB8716326D0/en
Priority claimed from GB878716324A external-priority patent/GB8716324D0/en
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of LU87268A1 publication Critical patent/LU87268A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/16—Somatostatin; related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
LU87268A 1987-07-10 1988-07-08 Composition pharmaceutique a base d'analogues de la somatostatine LU87268A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8716326 1987-07-10
GB878716326A GB8716326D0 (en) 1987-07-10 1987-07-10 Organic compounds
GB8716324 1987-07-10
GB878716324A GB8716324D0 (en) 1987-07-10 1987-07-10 Organic compounds

Publications (1)

Publication Number Publication Date
LU87268A1 true LU87268A1 (fr) 1989-03-08

Family

ID=26292476

Family Applications (1)

Application Number Title Priority Date Filing Date
LU87268A LU87268A1 (fr) 1987-07-10 1988-07-08 Composition pharmaceutique a base d'analogues de la somatostatine

Country Status (27)

Country Link
US (2) US5753618A (sv)
JP (1) JP2578477B2 (sv)
AU (1) AU618270B2 (sv)
BE (1) BE1001079A4 (sv)
CA (1) CA1328402C (sv)
CH (1) CH677449A5 (sv)
CS (1) CS411591A3 (sv)
CY (2) CY1631A (sv)
DE (2) DE3845000C2 (sv)
DK (2) DK174125B1 (sv)
ES (1) ES2010561A6 (sv)
FI (1) FI93308C (sv)
FR (1) FR2617714B1 (sv)
GB (1) GB2208200B (sv)
GR (1) GR1000172B (sv)
HK (1) HK16492A (sv)
HU (1) HU203480B (sv)
IE (1) IE61908B1 (sv)
IL (1) IL87044A0 (sv)
LU (1) LU87268A1 (sv)
MY (2) MY109309A (sv)
NL (1) NL194823C (sv)
NO (1) NO179359C (sv)
NZ (1) NZ225340A (sv)
PT (1) PT87957B (sv)
SE (2) SE503191C2 (sv)
SG (1) SG3692G (sv)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8813339D0 (en) * 1988-06-06 1988-07-13 Sandoz Ltd Improvements in/relating to organic compounds
PH30995A (en) * 1989-07-07 1997-12-23 Novartis Inc Sustained release formulations of water soluble peptides.
US5538739A (en) * 1989-07-07 1996-07-23 Sandoz Ltd. Sustained release formulations of water soluble peptides
US5626945A (en) * 1993-09-28 1997-05-06 International Paper Company Repulpable, water repellant paperboard
US6355613B1 (en) * 1996-07-31 2002-03-12 Peptor Limited Conformationally constrained backbone cyclized somatostatin analogs
AU3215597A (en) 1996-08-30 1998-03-19 Biomeasure Incorporated Method of inhibiting fibrosis with a somatostatin agonist
ES2167189B1 (es) 1999-12-17 2003-04-01 Lipotec Sa Formulacion farmaceutica estable para la administracion intravenosa o intramuscular, de principios activos peptidicos
US6316414B1 (en) 2000-07-31 2001-11-13 Dabur Research Foundation Somatostatin analogs for the treatment of cancer
KR100743212B1 (ko) * 2001-06-08 2007-07-26 소시에떼 더 콘세이유 더 레세르세 에 다플리까띠옹 시엔띠피끄, 에스.아.에스. 소마토스타틴-도파민 키메라 유사체
TWI287986B (en) * 2001-12-13 2007-10-11 Novartis Ag Use of Epothilones for the treatment of the carcinoid syndrome
US20030207811A1 (en) * 2002-05-03 2003-11-06 Schrier Bruce K. Method of treating retinopathy of prematurity using somatostatin analogs
PL1787658T3 (pl) 2005-11-10 2012-08-31 Italfarmaco Spa Formulacje o przedłużonym uwalnianiu analogów somatostatyny będących inhibitorami hormonu wzrostu
CA2647986C (en) * 2006-03-31 2014-07-08 Erasmus University Medical Center Rotterdam Compositions for tumor growth control
US9517240B2 (en) 2006-09-26 2016-12-13 The Regents Of The University Of California Methods and compositions for cancer prevention and treatment
WO2008039482A2 (en) * 2006-09-26 2008-04-03 The Regents Of The University Of California Methods and compositions for cancer prevention and treatment
US20090325863A1 (en) * 2008-06-13 2009-12-31 Kleinberg David L Somatostatin analogs and IGF-I inhibition for breast cancer prevention
GB201016433D0 (en) 2010-09-30 2010-11-17 Q Chip Ltd Apparatus and method for making solid beads
GB201016436D0 (en) 2010-09-30 2010-11-17 Q Chip Ltd Method of making solid beads
WO2012074559A2 (en) * 2010-12-02 2012-06-07 New York University Treatment of non-proliferative cystic disease
KR102060207B1 (ko) * 2011-06-02 2019-12-30 더 리전츠 오브 더 유니버시티 오브 캘리포니아 세타-디펜신들로 염증성 프로테아제들의 차단
US9777039B2 (en) 2012-11-01 2017-10-03 Ipsen Pharma S.A.S. Somatostatin analogs and dimers thereof
TWI523863B (zh) 2012-11-01 2016-03-01 艾普森藥品公司 體抑素－多巴胺嵌合體類似物

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH621770A5 (en) * 1976-02-23 1981-02-27 Sandoz Ag Process for the preparation of novel peptide compounds
IT1105131B (it) * 1977-06-08 1985-10-28 Merck & Co Inc Peptidi analoghi della somatostatina dotati di piu' lunga e maggiore attivita' biologica e relativo procedimento di protezione
LU78191A1 (de) * 1977-09-28 1979-05-25 Ciba Geigy Ag Verfahren zur herstellung von neuen cyclopeptiden
US4328214A (en) * 1979-07-04 1982-05-04 Ciba-Geigy Corporation Cyclopeptides and pharmaceutical preparations thereof and also processes for their manufacture
US4900730A (en) * 1981-01-14 1990-02-13 Toyo Jozo Co., Ltd. Preparation which promotes the absorption of peptides
IE52535B1 (en) * 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
JPS57188526A (en) * 1981-05-14 1982-11-19 Takeda Chem Ind Ltd Peptide-containing pharmaceutical preparation
US4374060A (en) * 1981-07-15 1983-02-15 Merck & Co., Inc. Process for the preparation of cyclic hexapeptide
DE3264693D1 (en) * 1981-12-24 1985-08-14 Ciba Geigy Ag Cyclic octapeptides and pharmaceutical compositions thereof, and processes for their production and use
US4522813A (en) * 1983-10-27 1985-06-11 Merck & Co., Inc. Cyclic hexapeptide somatostatin analogs
HU195810B (en) * 1984-12-24 1988-07-28 Sandoz Ag Process for preparing new 8alpha-acyl-amino-ergoline derivatives and pharmaceutical compositions containing such compounds
US4725577A (en) * 1985-04-25 1988-02-16 Administrators Of The Tulane Educational Fund Biologically active lysine containing octapeptides
US4650787A (en) * 1985-04-25 1987-03-17 Schally Andrew Victor Biologically active octapeptides
ZW14486A1 (en) * 1985-07-29 1986-10-22 Smithkline Beckman Corp Pharmaceutical dosage unit
JPH085913B2 (ja) * 1985-09-12 1996-01-24 ザ・アドミニストレ−タ−ズ・オブ・ザ・ツ−レイン・エデユケイシヨナル・フアンド 治療用ソマトスタチン同族体
GR862206B (en) * 1985-09-12 1986-12-31 Univ Tulane Therapeutic somatostatin analogs
NL8701143A (nl) * 1986-05-27 1987-12-16 Sandoz Ag Farmaceutische preparaten.
NL194729C (nl) * 1986-10-13 2003-01-07 Novartis Ag Werkwijze voor de bereiding van peptidealcoholen via vaste fase.
AU639371B2 (en) * 1987-07-10 1993-07-22 Novartis Ag Method of treating breast cancer
US5187150A (en) * 1987-10-14 1993-02-16 Debiopharm S.A. Polyester-based composition for the controlled release of polypeptide medicinal substances
AU2284588A (en) * 1988-09-26 1990-03-29 Sandoz Ltd. Improvements in or relating to organic compounds
MY106120A (en) * 1988-12-05 1995-03-31 Novartis Ag Peptide derivatives.
US5384309A (en) * 1989-07-17 1995-01-24 Genentech, Inc. Cyclized peptides and their use as platelet aggregation inhibitors
JPH0532696A (ja) * 1990-09-28 1993-02-09 Takeda Chem Ind Ltd 副甲状腺ホルモン誘導体

Also Published As

Publication number Publication date
NO883054D0 (no) 1988-07-08
NL194823C (nl) 2003-04-03
DK385488A (da) 1989-01-11
CY1631A (en) 1992-07-10
FI93308B (sv) 1994-12-15
DK174125B1 (da) 2002-07-01
SE9301290D0 (sv) 1993-04-20
GB8816024D0 (en) 1988-08-10
ES2010561A6 (es) 1989-11-16
US5753618A (en) 1998-05-19
IE882091L (en) 1989-01-10
PT87957B (pt) 1995-03-01
JP2578477B2 (ja) 1997-02-05
DK200100558A (da) 2001-04-04
FI883261A (sv) 1989-01-11
IE61908B1 (en) 1994-11-30
NL194823B (nl) 2002-12-02
DE3822557C2 (de) 1998-07-02
FI883261A0 (sv) 1988-07-08
CA1328402C (en) 1994-04-12
SE503191C2 (sv) 1996-04-15
SE9301290A0 (sv) 1993-04-20
GB2208200A (en) 1989-03-15
CH677449A5 (sv) 1991-05-31
JPS6431728A (en) 1989-02-02
SG3692G (en) 1992-03-20
NZ225340A (en) 1991-05-28
HU203480B (en) 1991-08-28
HUT47865A (en) 1989-04-28
AU1889388A (en) 1989-01-12
MY109309A (en) 1997-01-31
BE1001079A4 (fr) 1989-07-04
NO179359C (no) 1996-09-25
DK174476B1 (da) 2003-04-14
GR880100458A (en) 1989-04-12
DE3822557A1 (de) 1989-01-19
SE8802569D0 (sv) 1988-07-08
DK385488D0 (da) 1988-07-08
GB2208200B (en) 1991-11-27
FI93308C (sv) 1995-03-27
CS411591A3 (en) 1992-06-17
MY103746A (en) 1993-09-30
PT87957A (pt) 1989-06-30
IL87044A0 (en) 1988-12-30
DE3845000C2 (de) 1998-11-19
NO179359B (no) 1996-06-17
HK16492A (en) 1992-03-06
NO883054L (no) 1989-01-11
AU618270B2 (en) 1991-12-19
FR2617714B1 (fr) 1991-09-20
NL8801734A (nl) 1989-02-01
CY1632A (en) 1992-07-10
GR1000172B (el) 1991-11-15
JPH0748272A (ja) 1995-02-21
FR2617714A1 (fr) 1989-01-13
SE8802569L (sv) 1989-01-11
JP2764041B2 (ja) 1998-06-11
US6066616A (en) 2000-05-23

Similar Documents

Publication Publication Date Title
LU87268A1 (fr) Composition pharmaceutique a base d'analogues de la somatostatine
US20030119736A1 (en) Methods for improving islet signaling in diabetes mellitus and for its prevention
CA2585116C (en) Sustained release formulation comprising bisphosphonate
BE1004038A4 (fr) Nouvelle utilisation therapeutique d'analogues ou de derives de la somatostatine.
CA2230968A1 (en) Method of treating insulin resistance
JP3784418B2 (ja) ソマトスタチン類似体およびラパマイシンの配合
BE1004645A3 (fr) Nouvelle utilisation therapeutique de peptides derives de la somatostatine.
WANG et al. Comparison of the effectiveness of 2-hourly versus 8-hourly subcutaneous injections of a somatostatin analog (SMS 201-995) in the treatment of acromegaly
BE1003762A3 (fr) Nouvelle utilisation therapeutique de la somatostatine et de ses analogues et derives.
US5409894A (en) Method of preventing balloon catheterization blood vessel damage
EP1545511B1 (en) Combined use of methylphenidate and melatonin for treating attention-deficit hyperactive disorder
JP2764041B6 (ja) ソマトスタチン類に関する改良
KR100195894B1 (ko) 소마토스타틴 동족체를 함유하는 약학 조성물
GB2239178A (en) Somatostatin analogues for the treatment of breast cancer
BE1003200A4 (fr) Nouveaux peptides de la somatostatine, leur preparation et leur utilisation comme medicaments.
JPH0559892B2 (sv)
WO2002009739A1 (en) Treatment of ocular disorders with somatostatin analogues
BE1013507A5 (fr) Formulations d'analogues de l'insuline.
JPH07258108A (ja) 有機化合物
FR2668933A1 (fr) Composition pharmaceutique a base de somatostatine.
RU97113692A (ru) Применение 3,4-дифенилхроманов для получения фармацевтической композиции для лечения или профилактики церебральных дегенеративных расстройств
RU97113495A (ru) Применение 3,4-дифенил хроманов для получения фармацевтической композиции для лечения или профилактики идиопатической или физиологической гинекомастии

Legal Events

Date Code Title Description
DT Application date
TA Annual fee